Liu F[Author] - Search Results

Year	Number of Results
1951	4
1952	1
1954	1
1959	1
1960	1
1961	1
1963	1
1964	1
1965	1
1966	3
1967	2
1968	2
1969	8
1970	3
1972	5
1973	4
1974	3
1975	3
1977	1
1978	5
1979	8
1980	11
1981	12
1982	21
1983	9
1984	20
1985	10
1986	27
1987	23
1988	45
1989	34
1990	45
1991	49
1992	46
1993	59
1994	78
1995	78
1996	104
1997	98
1998	82
1999	87
2000	137
2001	156
2002	193
2003	246
2004	290
2005	371
2006	415
2007	467
2008	582
2009	667
2010	752
2011	1012
2012	1136
2013	1306
2014	1615
2015	1824
2016	1884
2017	2104
2018	2441
2019	2695
2020	3005
2021	3390
2022	3934
2023	3809
2024	4282
2025	5047
2026	870

1

Integrative proteogenomic analysis provides molecular insights and clinical significance in gallbladder cancer.

Fu Z, Song Y, Liu F, Chen L, Cai S, Cui P, Wang G, Xie W, Zhang S, Ding L, Wang P, Zhang B, Rodriguez H, Feng F, Zhang X, Gong W, Gao Q, Gao D, Zhou H, Fan J. Fu Z, et al. Among authors: liu f. Cancer Cell. 2026 Feb 9;44(2):405-423.e13. doi: 10.1016/j.ccell.2025.12.014. Epub 2026 Jan 8. Cancer Cell. 2026. PMID: 41512870

2

SLC2A1⁺ tumour-associated macrophages spatially control CD8⁺ T cell function and drive resistance to immunotherapy in non-small-cell lung cancer.

Wang L, Chu H, Chen D, Wei Y, Jia J, Li L, He L, Peng L, Liu F, Huang S, Jin Z, Zhou D, Fang W, Jiang T, Xu S, Ding X, Cai H, Liu X, Jia Q, Zhu B, Chu Q. Wang L, et al. Among authors: liu f. Nat Cell Biol. 2026 Feb;28(2):338-348. doi: 10.1038/s41556-025-01840-5. Epub 2026 Jan 7. Nat Cell Biol. 2026. PMID: 41501177

3

Diabetes and its complications: molecular mechanisms, prevention and treatment.

Zhao L, Yuan J, Yang Q, Ma J, Yang F, Zou Y, Liu K, Liu F. Zhao L, et al. Among authors: liu f. Signal Transduct Target Ther. 2026 Jan 19;11(1):22. doi: 10.1038/s41392-025-02401-w. Signal Transduct Target Ther. 2026. PMID: 41549124 Free PMC article. Review.

4

Engineered outer membrane vesicles enhance solid tumour CAR-T cell therapy.

Li X, Li X, Shi J, Li Y, Zhang H, Chen T, Pang H, Zhang S, Luo S, Liu F, Li S, Ding C, Sun L, Xing F, Zheng T. Li X, et al. Among authors: liu f. Nat Biomed Eng. 2026 Jan 7. doi: 10.1038/s41551-025-01575-6. Online ahead of print. Nat Biomed Eng. 2026. PMID: 41501251

5

Protein foundation models: a comprehensive survey.

Xu H, Li L, Pan S, Cheng P, Wang Y, Rong Z, Liu F, Huang X, Wang S, Shu W. Xu H, et al. Among authors: liu f. Sci China Life Sci. 2026 Jan 5. doi: 10.1007/s11427-025-3147-2. Online ahead of print. Sci China Life Sci. 2026. PMID: 41530646 Review.

6

Decoding mitochondrial signaling: neutrophil-tumor cell crosstalk in orchestrating cancer progression.

Shen Q, Pan X, Li J, Li Y, Lin J, Liu F, Jiang X, Zhang C, Pang B. Shen Q, et al. Among authors: liu f. J Transl Med. 2026 Jan 17. doi: 10.1186/s12967-025-07659-w. Online ahead of print. J Transl Med. 2026. PMID: 41547879 Free article. Review. No abstract available.

7

Ferroptosis in cancer toward molecular insights and clinical translation in pancreatic cancer.

Chen Q, Liu F, Zhang Y, Yan L, Wu Y, Xu D, Wu P, Yuan H, Jiang K. Chen Q, et al. Among authors: liu f. Mol Cancer. 2026 Jan 17. doi: 10.1186/s12943-025-02567-5. Online ahead of print. Mol Cancer. 2026. PMID: 41547783 Free article. Review. No abstract available.

8

Microbial metabolite FAD mobilizes adipocyte lipid remodeling to enhance cancer immunotherapy efficacy.

Tong T, Huang X, Li L, Hu M, Zhu X, Zhu B, Ma Y, Ning L, Jiang Y, Zhang Y, Zhou Y, Wang Z, Ding J, Zhao Y, Xuan B, Zhang Y, Xiao X, Fang JY, Hong J, Yin Y, Liu F, Chen H. Tong T, et al. Among authors: liu f. Cell Metab. 2026 Jan 21:S1550-4131(25)00543-1. doi: 10.1016/j.cmet.2025.12.012. Online ahead of print. Cell Metab. 2026. PMID: 41570815

9

ABCA1-targeting peptide alleviates atherosclerosis via counteracting endothelial dysfunction.

Liang B, Liu F, Fu C, Xu X, Huang X, Zheng H, Shen J, Wang P, Zhuang S, Zhang M, Xu J, Jiang J, Dai Q, Xu S, Chen C, Dong F, Zhu J, Yang Y, Wang Y, Fang S. Liang B, et al. Among authors: liu f. Cardiovasc Res. 2026 Jan 19:cvag012. doi: 10.1093/cvr/cvag012. Online ahead of print. Cardiovasc Res. 2026. PMID: 41554107 No abstract available.

10

Targeting SPAK suppresses progression and averts an immune exhaustive microenvironment in hepatocellular carcinoma.

Pan Y, Zeng C, He Y, Chang R, Wu J, Yuan C, Li H, Su C, Han M, Li P, Li X, Zhang H, Liu F, Liang H, Li Z, Wu M, Xia L, Liu J, Chen X, Zhang W, Zhang B, Ding ZY. Pan Y, et al. Among authors: liu f. Nat Commun. 2026 Jan 12;17(1):1414. doi: 10.1038/s41467-025-68156-8. Nat Commun. 2026. PMID: 41526378 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40,941 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40,941 results

Results by year